SE8401946L - Antikropp mot human prostatacancer - Google Patents

Antikropp mot human prostatacancer

Info

Publication number
SE8401946L
SE8401946L SE8401946A SE8401946A SE8401946L SE 8401946 L SE8401946 L SE 8401946L SE 8401946 A SE8401946 A SE 8401946A SE 8401946 A SE8401946 A SE 8401946A SE 8401946 L SE8401946 L SE 8401946L
Authority
SE
Sweden
Prior art keywords
prostatacances
antibody
antibody against
against human
cell
Prior art date
Application number
SE8401946A
Other languages
Unknown language ( )
English (en)
Other versions
SE8401946D0 (sv
Inventor
M Yoshimura
E Inoguchi
K Saito
Y Kobayashi
T Chiku
K Matsunaga
T Fujii
C Yoshikumi
Original Assignee
Kureha Chemical Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP58061917A external-priority patent/JPS59187796A/ja
Priority claimed from JP6192283A external-priority patent/JPS59186923A/ja
Priority claimed from JP6191983A external-priority patent/JPS59188557A/ja
Application filed by Kureha Chemical Ind Co Ltd filed Critical Kureha Chemical Ind Co Ltd
Publication of SE8401946D0 publication Critical patent/SE8401946D0/sv
Publication of SE8401946L publication Critical patent/SE8401946L/sv

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Gynecology & Obstetrics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SE8401946A 1983-04-08 1984-04-06 Antikropp mot human prostatacancer SE8401946L (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP58061917A JPS59187796A (ja) 1983-04-08 1983-04-08 抗ヒト前立腺癌抗体
JP6192283A JPS59186923A (ja) 1983-04-08 1983-04-08 ヒト前立腺癌治療用薬剤
JP6191983A JPS59188557A (ja) 1983-04-08 1983-04-08 ヒト前立腺癌の分類および同定用試薬

Publications (2)

Publication Number Publication Date
SE8401946D0 SE8401946D0 (sv) 1984-04-06
SE8401946L true SE8401946L (sv) 1984-11-13

Family

ID=27297684

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8401946A SE8401946L (sv) 1983-04-08 1984-04-06 Antikropp mot human prostatacancer

Country Status (4)

Country Link
DE (1) DE3413341A1 (sv)
FR (1) FR2551085A1 (sv)
GB (1) GB2139645A (sv)
SE (1) SE8401946L (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4970299A (en) * 1986-07-03 1990-11-13 Sloan-Kettering Institute For Cancer Research Monoclonal antibodies selective for prostate cancer
JPH0249596A (ja) * 1988-08-09 1990-02-19 Masamichi Ueda ヒト前立腺上皮細胞の表面に特異的に反応するモノクローナル抗体

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486538A (en) * 1978-07-07 1984-12-04 Samuel Bogoch Detection of malignant tumor cells
JPS57500169A (sv) * 1979-12-28 1982-01-28
US4650756A (en) * 1981-08-31 1987-03-17 Sloan Kettering Institute For Cancer Research Monoclonal antibodies to cell surface antigens of human renal cancer
ES8404857A1 (es) * 1981-10-27 1984-05-16 Hybritech Inc Un procedimiento para preparar un anticuerpo monoclonal para un antigeno asociado a un tumor.
EP0087898A1 (en) * 1982-02-22 1983-09-07 Cancer Research Campaign Technology Limited Antibodies and antigens useful in the diagnosis and treatment of cancer
DE3211356A1 (de) * 1982-03-27 1983-09-29 Behringwerke Ag, 3550 Marburg Zell-hybrid, verfahren zu seiner herstellung sowie seine verwendung

Also Published As

Publication number Publication date
GB8408988D0 (en) 1984-05-16
FR2551085A1 (sv) 1985-03-01
GB2139645A (en) 1984-11-14
SE8401946D0 (sv) 1984-04-06
DE3413341A1 (de) 1984-11-22

Similar Documents

Publication Publication Date Title
KR880700061A (ko) 인체 암종양과 관련된 항원에 대한 단클론성 항체
ATE130029T1 (de) Hybridome, die monoklonale antikörper gegen neue mucin-epitope produzieren.
IL93840A0 (en) Novel monoclonal antibody to novel antigen associated with human tumors
JPS6447378A (en) Monoclonal antibody to black tumor related antigen, hybrid cell line for producing the same and use thereof
ATE171207T1 (de) Monoklonaler antikörper
PT72301A (en) Process for the detection of human cancer cells with antibodies to human cancer nucleolar antigens
SE8401943D0 (sv) Antibody to fungl of candida
EP0460607A3 (en) Novel monoclonal antibody to novel antigen associated with human tumors
SE8401946L (sv) Antikropp mot human prostatacancer
IT8026986A0 (it) Antigene di prostata umana purificato e procedimento per preparare anticorpi correlati a tale antigene.
SE8401944D0 (sv) Antibody to fungi of aspergillus
SE8401945D0 (sv) Antibody to human urinary bladder cancer
DK102589A (da) Antigen, der genkendes af mca 16-88
ATE138200T1 (de) Das von mca-28a32 erkannte antigen
IL67944A0 (en) Antibodies and antigens useful in the diagnosis and treatment of cancer,methods for the production thereof and methods for testing for the presence of cancer cells using the same
ZW4783A1 (en) Antibodies and antigens useful in the diagnosis and treatment of cancer
ZA831050B (en) Antibodies and antigens useful in the diagnosis and treatment of cancer
BG50103A1 (en) Hybridome cell line, secretting monoclonal antibody against antigene determinante noc- 2 of malignant melanom in human

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8401946-2

Effective date: 19871101

Format of ref document f/p: F